Turning back the clock.

Area of Science:

• Gerontology
• Molecular Biology
• Muscle Physiology

Background:

• Aging skeletal muscle is characterized by increased DNA damage.
• DNA damage response pathways, such as DNA-activated protein kinase (DNA-PK), are activated in aging tissues.
• Accumulated DNA damage contributes to age-related functional decline and metabolic dysfunction.

Purpose of the Study:

• To investigate the role of the DNA-PK pathway in age-related skeletal muscle dysfunction.
• To determine if inhibiting the DNA-PK pathway can ameliorate aging phenotypes in skeletal muscle.

Main Methods:

• Utilized a mouse model of aging.
• Assessed DNA breaks and DNA-PK pathway activation in skeletal muscle.
• Administered a DNA-PK inhibitor to aged mice.
• Evaluated mitochondrial density, physical fitness (e.g., endurance), body weight, and insulin resistance.

Main Results:

• Increased DNA breaks and DNA-PK pathway activation were observed in aging skeletal muscle.
• Inhibition of the DNA-PK pathway in aged mice led to significant improvements in mitochondrial density.
• Blocking DNA-PK also enhanced physical fitness and improved body weight regulation.
• Insulin resistance was notably reduced in mice treated with the DNA-PK inhibitor.

Conclusions:

• The DNA-PK pathway is a key mediator of age-related skeletal muscle decline.
• Targeting the DNA-PK pathway represents a promising therapeutic strategy to combat aging phenotypes.
• Interventions aimed at DNA repair pathways may restore muscle function and metabolic health in aging populations.